Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11961)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2017 (publication date) through Nov 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Le Grazie M, Biagini MR, Tarocchi M, Polvani S, Galli A. Chemotherapy for hepatocellular carcinoma: The present and the future. World J Hepatol 2017; 9(21): 907-920 [PMID: 28824742 DOI: 10.4254/wjh.v9.i21.907] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i21/907.htm |
| Number | Citing Articles |
| 1 |
Saleh A. Alanazi, Gamaleldin I. Harisa, Mohamed M. Badran, Fars K. Alanazi, Ehab Elzayat, Abdullah H. Alomrani, Osaid T. Al Meanazel, Ahmed T. Al Meanazel. Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition. Bioengineered 2021; 12(1): 914 doi: 10.1080/21655979.2021.1896202
|
| 2 |
Shuyue Yang, Jiaxin Wang, Shidong Wang, Anni Zhou, Guiping Zhao, Peng Li. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review). International Journal of Oncology 2022; 61(2) doi: 10.3892/ijo.2022.5381
|
| 3 |
Wen-jun Ge, Huan Huang, Tao Wang, Wei-hong Zeng, Min Guo, Chen-ran Ren, Ting-yu Fan, Fang Liu, Xi Zeng. Long non-coding RNAs in hepatocellular carcinoma. Pathology - Research and Practice 2023; 248: 154604 doi: 10.1016/j.prp.2023.154604
|
| 4 |
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, Ugo Randazzo, Alessia Fiorino, Marianna Di Piazza, Chiara Brando, Luigi Magrin, Silvia Contino, Paola Piraino, Tancredi Didier Bazan Russo, Calogero Cipolla, Antonio Russo, Viviana Bazan. Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?. Critical Reviews in Oncology/Hematology 2023; 190: 104086 doi: 10.1016/j.critrevonc.2023.104086
|
| 5 |
Xiaohong Wen, Zhixiang Huang, Xiaohai Yang, Xiaoxiao He, Lie Li, Haiyan Chen, Kemin Wang, Qiuping Guo, Jianbo Liu. Development of an aptamer capable of multidrug resistance reversal for tumor combination chemotherapy. Proceedings of the National Academy of Sciences 2024; 121(15) doi: 10.1073/pnas.2321116121
|
| 6 |
Mihaela Turtoi, Maria Anghelache, Andrei A. Patrascu, Mariana Deleanu, Geanina Voicu, Mihai Raduca, Florentina Safciuc, Ileana Manduteanu, Manuela Calin, Delia-Laura Popescu. Antitumor Properties of a New Macrocyclic Tetranuclear Oxidovanadium(V) Complex with 3-Methoxysalicylidenvaline Ligand. Biomedicines 2022; 10(6): 1217 doi: 10.3390/biomedicines10061217
|
| 7 |
Shu-Cai Xie, Jian-Quan Zhang, Xi-Li Jiang, Yong-Yong Hua, Shao-Wei Xie, Ye-Ang Qin, Yi-Jun Yang. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma. Cell Death & Disease 2020; 11(8) doi: 10.1038/s41419-020-02853-8
|
| 8 |
Erik Soule, Sanjay Lamsal, Chandana Lall, Jerry Matteo. Eye Opener to EtOH Ablation for Juxta-Cardiac Hepatocellular Carcinoma. Gastrointestinal Tumors 2018; 5(3-4): 109 doi: 10.1159/000495135
|
| 9 |
Zheng-Yuan Xie, Mao-Sheng Liu, Cong Zhang, Peng-Cheng Cai, Zhi-Hua Xiao, Fen-Fen Wang. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180854
|
| 10 |
Alican Özkan, Danielle L. Stolley, Erik N. K. Cressman, Matthew McMillin, Sharon DeMorrow, Thomas E. Yankeelov, Marissa Nichole Rylander. Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.662135
|
| 11 |
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos‐Gómez, Diana Vara‐Ciruelos, Nieves Rodríguez‐Henche, Inés Díaz‐Laviada. Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib. Molecular Oncology 2019; 13(5): 1311 doi: 10.1002/1878-0261.12488
|
| 12 |
Xiujuan Yin, Jing Rong, Min Shao, Saisai Zhang, Likang Yin, Zhenqiang He, Xiao Wang. Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02486-5
|
| 13 |
Eunsun Kim, Patrick Viatour. Hepatocellular carcinoma: old friends and new tricks. Experimental & Molecular Medicine 2020; 52(12): 1898 doi: 10.1038/s12276-020-00527-1
|
| 14 |
Jose J.G. Marin, Marta R. Romero, Elisa Herraez, Maitane Asensio, Sara Ortiz-Rivero, Anabel Sanchez-Martin, Luca Fabris, Oscar Briz. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems. Seminars in Liver Disease 2022; 42(01): 087 doi: 10.1055/s-0041-1735631
|
| 15 |
Kajal Singh, Pradeep Kumar, Amit Kumar Singh, Nancy Singh, Sakshi Singh, Kavindra Nath Tiwari, Shreni Agrawal, Richa Das, Anuradha Singh, Bhuwal Ram, Amit Kumar Tripathi, Sunil Kumar Mishra. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC. Medical Oncology 2024; 41(6) doi: 10.1007/s12032-024-02374-w
|
| 16 |
Nighat Gull, Fareeha Arshad, Gowhar A. Naikoo, Israr Ul Hassan, Mona Zamani Pedram, Arif Ahmad, Alaa A. A. Aljabali, Vijay Mishra, Saurabh Satija, Nitin Charbe, Poonam Negi, Rohit Goyal, Ángel Serrano-Aroca, Mazhar S. Al Zoubi, Mohamed El-Tanani, Murtaza M. Tambuwala. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2023; 54(2): 368 doi: 10.1007/s12029-022-00809-z
|
| 17 |
Xiaofeng Sun, Chengjian Zhou, Simin Xia, Xi Chen. Small molecule-nanobody conjugate induced proximity controls intracellular processes and modulates endogenous unligandable targets. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-37237-x
|
| 18 |
Lin Zhang, Lingli Zhou, Hui Zhang, Yibin Zhang, Ling Li, Tiantian Xie, Yinglei Chen, Xiaodong Li, Neng Ling, Jing Dai, Xing Sun, Jing Liu, Jinfeng Zhao, Tianhuan Peng, Mao Ye. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for In Vivo Imaging. ACS Applied Materials & Interfaces 2021; 13(46): 54656 doi: 10.1021/acsami.1c12391
|
| 19 |
Hasibe Vural, Pınar Özden, Ebru Avcı. Ginnalin A and SB203580 show additive effect on Hep-3B hepatocellular carcinoma cell line. Turkish Journal of Biochemistry 2019; 44(1): 78 doi: 10.1515/tjb-2018-0099
|
| 20 |
Lorenza Rimassa, Marcus‐Alexander Wörns. Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma. Liver International 2020; 40(8): 1800 doi: 10.1111/liv.14533
|
| 21 |
Meenu Chopra, Agustin Sgro, Marck Norret, Pilar Blancafort, K. Swaminathan Iyer, Cameron W. Evans. SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination. ACS Applied Bio Materials 2021; 4(1): 1023 doi: 10.1021/acsabm.0c01468
|
| 22 |
Antonella Di Sotto, Hamid Irannejad, Margherita Eufemi, Romina Mancinelli, Lorena Abete, Caterina Loredana Mammola, Fabio Altieri, Gabriela Mazzanti, Silvia Di Giacomo. Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study. International Journal of Molecular Sciences 2020; 21(2): 633 doi: 10.3390/ijms21020633
|
| 23 |
HE Abo Mansour, MM El-Batsh, NS Badawy, ET Mehanna, NM Mesbah, DM Abo-Elmatty. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice. Human & Experimental Toxicology 2020; 39(11): 1528 doi: 10.1177/0960327120930266
|
| 24 |
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Current Medicinal Chemistry 2020; 27(39): 6611 doi: 10.2174/0929867326666190911115722
|
| 25 |
Rhys Gillman, Kylie Lopes Floro, Miriam Wankell, Lionel Hebbard. The role of DNA damage and repair in liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1): 188493 doi: 10.1016/j.bbcan.2020.188493
|
| 26 |
L. S. Klyushova, Yu. A. Golubeva, V. A. Vavilin, A. Yu. Grishanova. Modulating effect of Cu(II) complexes with enamine and tetrazole derivatives on CYP2C and CYP3A and their cytotoxic and antiproliferative properties in HepG2 spheroids. Acta Biomedica Scientifica 2022; 7(5-2): 31 doi: 10.29413/ABS.2022-7.5-2.4
|
| 27 |
Eugenio Redolfi Riva, Edoardo Sinibaldi, Agostina Francesca Grillone, Serena Del Turco, Alessio Mondini, Tianshu Li, Shinji Takeoka, Virgilio Mattoli. Enhanced In Vitro Magnetic Cell Targeting of Doxorubicin-Loaded Magnetic Liposomes for Localized Cancer Therapy. Nanomaterials 2020; 10(11): 2104 doi: 10.3390/nano10112104
|
| 28 |
Muhammad Yogi Pratama, Luisa Cavalletto, Claudio Tiribelli, Liliana Chemello, Devis Pascut. Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59682-0
|
| 29 |
Shanzhou Huang, Zuyi Ma, Chengjun Sun, Qi Zhou, Zhenchong Li, Shujie Wang, Qian Yan, Chunsheng Liu, Baohua Hou, Chuanzhao Zhang. An injectable thermosensitive hydrogel loaded with a theranostic nanoprobe for synergistic chemo–photothermal therapy for multidrug-resistant hepatocellular carcinoma. Journal of Materials Chemistry B 2022; 10(15): 2828 doi: 10.1039/D2TB00044J
|
| 30 |
Danlei Chen, Jinghao Wang, Yang Li, Chenglin Xu, Meng Fanzheng, Pengfei Zhang, Lianxin Liu. LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11‐dependent repression of CDKN2A. Clinical and Translational Medicine 2023; 13(9) doi: 10.1002/ctm2.1418
|
| 31 |
Archana Chaudhary, Sadhan Kumar Bhardwaj, Azmi Khan, Amrita Srivastava, Kislay Kumar Sinha, Mehboob Ali, Rizwanul Haque. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer. Biological Trace Element Research 2023; 201(7): 3300 doi: 10.1007/s12011-022-03430-0
|
| 32 |
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar, Md Nurunnabi. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 2021; 9(14): 4821 doi: 10.1039/D1BM00167A
|
| 33 |
Jared H. Gans, Jeffrey Lipman, Yosef Golowa, Milan Kinkhabwala, Andreas Kaubisch. Hepatic Cancers Overview: Surgical and Chemotherapeutic Options, How Do Y-90 Microspheres Fit in?. Seminars in Nuclear Medicine 2019; 49(3): 170 doi: 10.1053/j.semnuclmed.2019.01.001
|
| 34 |
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber, Ebtessam A. Essa, Sanaa A. El-Gizawy. Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a N-Nitrosodiethylamine-Induced Mice Model of Hepatocellular Carcinoma. Molecular Pharmaceutics 2023; 20(9): 4758 doi: 10.1021/acs.molpharmaceut.3c00542
|
| 35 |
Gabriel Siracusano, Maria Tagliamonte, Luigi Buonaguro, Lucia Lopalco. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines 2020; 8(1): 41 doi: 10.3390/vaccines8010041
|
| 36 |
Tehreem Fatima, Mian Muhammad Mubasher, Hafiz Muhammad Rehman, Sakina Niyazi, Abdullah R. Alanzi, Maria Kalsoom, Sania Khalid, Hamid Bashir. Computational modeling study of IL-15-NGR peptide fusion protein: a targeted therapeutics for hepatocellular carcinoma. AMB Express 2024; 14(1) doi: 10.1186/s13568-024-01747-8
|
| 37 |
Vangelis Kondylis, Manolis Pasparakis. RIP Kinases in Liver Cell Death, Inflammation and Cancer. Trends in Molecular Medicine 2019; 25(1): 47 doi: 10.1016/j.molmed.2018.10.007
|
| 38 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 39 |
Özlem Kaplan. Synergistic induction of apoptosis in liver cancer cells: exploring the combined potential of doxorubicin and XL-888. Medical Oncology 2023; 40(11) doi: 10.1007/s12032-023-02181-9
|
| 40 |
Li-Fang Chou, Chi-Yuan Chen, Wan-Hua Yang, Chin-Chuan Chen, Junn-Liang Chang, Yann-Lii Leu, Miaw-Jene Liou, Tong-Hong Wang. Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression. Biomolecules 2019; 10(1): 20 doi: 10.3390/biom10010020
|
| 41 |
Hyungjin Kim, Hyo-Jung Lee, Deok Yong Sim, Ji Eon Park, Chi-Hoon Ahn, Su-Yeon Park, Eungyeong Jang, Bonglee Kim, Sung-Hoon Kim. The Antitumor Effect of Cinnamaldehyde Derivative CB-PIC in Hepatocellular Carcinoma Cells via Inhibition of Pyruvate and STAT3 Signaling. International Journal of Molecular Sciences 2022; 23(12): 6461 doi: 10.3390/ijms23126461
|
| 42 |
Bailu Yang, Fukai Wen, Yifeng Cui. Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(20) doi: 10.1111/jcmm.70083
|
| 43 |
Sung Hyun Kim, Myoung-Ok Kim, Ki-Rim Kim. Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells. Journal of Cancer Prevention 2018; 23(4): 170 doi: 10.15430/JCP.2018.23.4.170
|
| 44 |
Archu Singh, Sadat Shafi, Tanya Upadhyay, Abul Kalam Najmi, Kanchan Kohli, Faheem Hyder Pottoo. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Current Topics in Medicinal Chemistry 2020; 20(20): 1839 doi: 10.2174/1568026620666200624161801
|
| 45 |
Hamid B. Aliabad, Maryam Mohamadi, Soudeh K. Falahati-Pour, Mohammad R. Hajizadeh, Danial Abdollahdokht, Mohammad H. Nematollahi, Mehdi Mahmoodi. Interaction of a Vanadyl Schiff Base Complex with DNA and BSA: A Combination of Experimental and Computational Studies. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(5): 630 doi: 10.2174/1871520620666200721105134
|
| 46 |
Alessandro Corti, Silvia Dominici, Simona Piaggi, Alfonso Pompella. Enhancement of ferroptosis by boric acid and its potential use as chemosensitizer in anticancer chemotherapy. BioFactors 2023; 49(2): 405 doi: 10.1002/biof.1919
|
| 47 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.524205
|
| 48 |
Qi Xu, Qiuting Li, Zhe Yang, Piao Huang, Han Hu, Zhimin Mo, Zizhen Qin, Zushun Xu, Tianyou Chen, Shengli Yang. Lenvatinib and Cu2−xS nanocrystals co-encapsulated in poly(d,l-lactide-co-glycolide) for synergistic chemo-photothermal therapy against advanced hepatocellular carcinoma. Journal of Materials Chemistry B 2021; 9(48): 9908 doi: 10.1039/D1TB01808F
|
| 49 |
Chi-Yuan Chen, Chin-Chuan Chen, Tzong-Ming Shieh, Chuen Hsueh, Shu-Huei Wang, Yann-Lii Leu, Jang-Hau Lian, Tong-Hong Wang. Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5. International Journal of Molecular Sciences 2018; 19(2): 380 doi: 10.3390/ijms19020380
|
| 50 |
Mohamed M. Tawfik, Nourhan Eissa, Fayez Althobaiti, Eman Fayad, Ali H. Abu Almaaty. Nomad Jellyfish Rhopilema nomadica Venom Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Hepatocellular Carcinoma HepG2 Cells. Molecules 2021; 26(17): 5185 doi: 10.3390/molecules26175185
|
| 51 |
Surabhi Pathak, Mohamad Sonbol. Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction. Journal of Hepatocellular Carcinoma 2021; : 1147 doi: 10.2147/JHC.S268314
|
| 52 |
Mingang He, Wenchao Gu, Yang Gao, Ying Liu, Jie Liu, Zengjun Li. Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1043827
|
| 53 |
Sherien M. El-Daly, Shaimaa A. Gouhar, Amira M. Gamal-Eldeen, Fatma F. Abdel Hamid, Magdi N. Ashour, Nahla S. Hassan. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells. Anti-Cancer Agents in Medicinal Chemistry 2020; 19(18): 2197 doi: 10.2174/1871520619666190930123520
|
| 54 |
Anna J Shangguan, Kang Zhou, Jia Yang, Aydin Eresen, Bin Wang, Chong Sun, Liang Pan, Su Hu, Ali T Khan, Samdeep K Mouli, Vahid Yaghmai, Zhuoli Zhang. <p>Intraprocedural Transcatheter Intraarterial Perfusion (TRIP)-MRI for Evaluation of Irreversible Electroporation Therapy Response in a Rabbit Liver Tumor Model</p>. Clinical and Experimental Gastroenterology 2020; : 543 doi: 10.2147/CEG.S269163
|
| 55 |
Yi-Lin Hu, Ying Feng, Peng Ma, Fei Wang, Hua Huang, Yi-Bing Guo, Peng Li, Qin-Sheng Mao, Wan-Jiang Xue. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial–mesenchymal transition via the NF-κB pathway. Experimental Cell Research 2019; 381(1): 66 doi: 10.1016/j.yexcr.2019.04.030
|
| 56 |
Wei Zhang, Jingxin Zhang, Chenzhou Xu, Shiqing Zhang, Saiyan Bian, Feng Jiang, Wenkai Ni, Lishuai Qu, Cuihua Lu, Runzhou Ni, Yihui Fan, Mingbing Xiao, Jinxia Liu. Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1109-2
|
| 57 |
Madelyn Miller, Shadab A. Siddiqi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 377 doi: 10.1016/B978-0-323-99283-1.00008-2
|
| 58 |
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 2023; 3(1): 121 doi: 10.3390/livers3010011
|
| 59 |
Wei Zhou, Weiyang Lou, Junru Chen, Bisha Ding, Binjie Chen, Haiyang Xie, Lin Zhou, Shusen Zheng, Donghai Jiang. AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest. OncoTargets and Therapy 2021; : 1049 doi: 10.2147/OTT.S289324
|
| 60 |
军 刘. Research Progress of Immune Checkpoint Inhibitors in the Treatment of Primary Liver Cancer. Advances in Clinical Medicine 2022; 12(04): 3360 doi: 10.12677/ACM.2022.124486
|
| 61 |
Kiyoon Min, Sathish Kumar Karuppannan, Giyoong Tae. The impact of matrix stiffness on hepatic cell function, liver fibrosis, and hepatocellular carcinoma—Based on quantitative data. Biophysics Reviews 2024; 5(2) doi: 10.1063/5.0197875
|
| 62 |
Shengnan Liu, Yang Du, He Ma, Qian Liang, Xu Zhu, Jie Tian. Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging. Cancer Letters 2019; 453: 74 doi: 10.1016/j.canlet.2019.03.037
|
| 63 |
Khadijeh Mahboobnia, Matteo Pirro, Ettore Marini, Francesco Grignani, Evgeny E. Bezsonov, Tannaz Jamialahmadi, Amirhossein Sahebkar. PCSK9 and cancer: Rethinking the link. Biomedicine & Pharmacotherapy 2021; 140: 111758 doi: 10.1016/j.biopha.2021.111758
|
| 64 |
Morteza Abyadeh, Anna Meyfour, Vivek Gupta, Masoud Zabet Moghaddam, Matthew J. Fitzhenry, Shila Shahbazian, Ghasem Hosseini Salekdeh, Mehdi Mirzaei. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers. International Journal of Molecular Sciences 2020; 21(22): 8532 doi: 10.3390/ijms21228532
|
| 65 |
Nick Freemantle, Patrick Mollon, Tim Meyer, Ann-Lii Cheng, Anthony B. El-Khoueiry, Robin K. Kelley, Ari D. Baron, Fawzi Benzaghou, Milan Mangeshkar, Ghassan K. Abou-Alfa. Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial. European Journal of Cancer 2022; 168: 91 doi: 10.1016/j.ejca.2022.03.021
|
| 66 |
Neha N. Parayath, Smrithi Padmakumar, Mansoor M. Amiji. Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment. Cancer Letters 2020; 482: 33 doi: 10.1016/j.canlet.2020.04.009
|
| 67 |
Tamer A. Al-Shafie, Engy A. Mahrous, Mustafa Shukry, Mohammad Y. Alshahrani, Samah F. Ibrahim, Liana Fericean, Afaf Abdelkader, Mennatallah A. Ali. A Proposed Association between Improving Energy Metabolism of HepG2 Cells by Plant Extracts and Increasing Their Sensitivity to Doxorubicin. Toxics 2023; 11(2): 182 doi: 10.3390/toxics11020182
|
| 68 |
Fabio Ciccarone, Serena Castelli, Maria Rosa Ciriolo. Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/6050123
|
| 69 |
Hewen Shi, Ying Zou, Weiwei Zhong, Zhaoying Li, Xiaoxue Wang, Yancun Yin, Defang Li, Ying Liu, Minjing Li. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15311 doi: 10.1007/s00432-023-05272-2
|
| 70 |
Merna G. Aboismaiel, Mohamed El-Mesery, Amro El-Karef, Mamdouh M. El-Shishtawy. Hesperetin upregulates Fas/FasL expression and potentiates the antitumor effect of 5-fluorouracil in rat model of hepatocellular carcinoma. Egyptian Journal of Basic and Applied Sciences 2020; 7(1): 20 doi: 10.1080/2314808X.2019.1707627
|
| 71 |
Florian Nima Fleckenstein, Maximilian Julius Roesel, Maja Krajewska, Timo Alexander Auer, Federico Collettini, Tazio Maleitzke, Georg Böning, Giovanni Federico Torsello, Uli Fehrenbach, Bernhard Gebauer. Combining Transarterial Radioembolization (TARE) and CT-Guided High-Dose-Rate Interstitial Brachytherapy (CT-HDRBT): A Retrospective Analysis of Advanced Primary and Secondary Liver Tumor Treatment. Cancers 2021; 14(1): 72 doi: 10.3390/cancers14010072
|
| 72 |
Fei Cao, Li-Xue Yin. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Experimental and Molecular Pathology 2019; 106: 34 doi: 10.1016/j.yexmp.2018.10.009
|
| 73 |
Anroop B. Nair, Jigar Shah, Bandar E. Al-Dhubiab, Snehal S. Patel, Mohamed A. Morsy, Vimal Patel, Vishal Chavda, Shery Jacob, Nagaraja Sreeharsha, Pottathil Shinu, Mahesh Attimarad, Katharigatta N. Venugopala. Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma. Molecules 2019; 24(24): 4566 doi: 10.3390/molecules24244566
|
| 74 |
Devis Pascut, Muhammad Yogi Pratama, Niem V.T. Vo, Rina Masadah, Claudio Tiribelli. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications. Cancers 2020; 12(4): 823 doi: 10.3390/cancers12040823
|
| 75 |
Xiaowei Wang, Yiran Zheng, Chang Bao, Guansheng Zhong, Shaoqiong Liu, Nikken Wiradharma, Weimin Fan, Yi Yan Yang, Xiaojia Wang, Yuan Huang. Branched α-helical peptides enhanced antitumor efficacy and selectivity. Biomaterials Science 2020; 8(22): 6387 doi: 10.1039/D0BM00629G
|
| 76 |
Toshiya Sakamoto, Satoshi Kuboki, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Arihito Yoshizumi, Masayuki Ohtsuka. TRIM27‐USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. Liver International 2023; 43(1): 194 doi: 10.1111/liv.15346
|
| 77 |
Elena Ruxandra Radu, Augustin Semenescu, Stefan Ioan Voicu. Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy. Polymers 2022; 14(23): 5249 doi: 10.3390/polym14235249
|
| 78 |
Junan Qi, Jun Li, Beibei Bie, Mengjiao Shi, Mengchen Zhu, Jing Tian, Kai Zhu, Jin Sun, Yanhua Mu, Zongfang Li, Ying Guo. miR‐3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10. Phytotherapy Research 2023; 37(1): 295 doi: 10.1002/ptr.7613
|
| 79 |
Dipti Athavale, Surbhi Chouhan, Vimal Pandey, Shyamananda Singh Mayengbam, Snahlata Singh, Manoj Kumar Bhat. Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9). Cancer & Metabolism 2018; 6(1) doi: 10.1186/s40170-018-0187-2
|
| 80 |
Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, Shih-Hsuan Chan. Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma. Cancers 2020; 12(7): 1843 doi: 10.3390/cancers12071843
|
| 81 |
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
|
| 82 |
Hamid Bakhshi Aliabad, Soudeh Khanamani Falahati-pour, Hadis Ahmadirad, Maryam Mohamadi, Mohammad Reza Hajizadeh, Mehdi Mahmoodi. Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells. BioMetals 2018; 31(6): 981 doi: 10.1007/s10534-018-0139-x
|
| 83 |
Keisaku Sato, Fanyin Meng, Heather Francis, Nan Wu, Lixian Chen, Lindsey Kennedy, Tianhao Zhou, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies. Journal of Pineal Research 2020; 68(3) doi: 10.1111/jpi.12639
|
| 84 |
Abdullah Alhusaini, Aoife Cannon, Stephen G. Maher, John V. Reynolds, Niamh Lynam-Lennon. Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers. Biomedicines 2021; 9(8): 1024 doi: 10.3390/biomedicines9081024
|
| 85 |
Jin Hong Lim, Keunwan Park, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Seok-Mo Kim, Ki Cheong Park. Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(14): 7971 doi: 10.3390/ijms23147971
|
| 86 |
Alican Özkan, Danielle L. Stolley, Erik N. K. Cressman, Matthew McMillin, Thomas E. Yankeelov, Marissa Nichole Rylander. Vascularized Hepatocellular Carcinoma on a Chip to Control Chemoresistance through Cirrhosis, Inflammation and Metabolic Activity. Small Structures 2023; 4(9) doi: 10.1002/sstr.202200403
|
| 87 |
Antonella Di Sotto, Silvia Di Giacomo, Elisabetta Rubini, Alberto Macone, Marco Gulli, Caterina Loredana Mammola, Margherita Eufemi, Romina Mancinelli, Gabriela Mazzanti. Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention. Cells 2020; 9(4): 858 doi: 10.3390/cells9040858
|
| 88 |
Debashri Manna, Devanand Sarkar. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma. Cancers 2020; 12(5): 1243 doi: 10.3390/cancers12051243
|
| 89 |
Bushan Xie, Xingxing He, Guihai Guo, Xiao Zhang, Jinping Li, Jianping Liu, Yingbo Lin. High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement. Biochemical and Biophysical Research Communications 2020; 521(1): 232 doi: 10.1016/j.bbrc.2019.10.114
|
| 90 |
Xitian Liang, Bolin Wu, Haitao Shang, Xue Han, Hui Jing, Yixin Sun, Wen Cheng. VTIQ evaluates antitumor effects of NET‑1 siRNA by UTMD in HCC xenograft models. Oncology Letters 2018; doi: 10.3892/ol.2018.8994
|
| 91 |
Biao Tang, Longhui Xie, Xin Tang, Junjie Tian, Shaofei Xiao. Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in cell stemness and gemcitabine resistance of hepatocellular carcinoma. Molecular and Cellular Probes 2023; 71: 101924 doi: 10.1016/j.mcp.2023.101924
|
| 92 |
Yongxin Qiu, Yi Dai, Chi Zhang, Ye Yang, Ming Jin, Wenqi Shan, Jian Shen, Ming Lu, Zhaoyang Tang, Liang Ju, Yuting Wang, Ruonan Jiao, Yunwei Xia, Guangming Huang, Lihua Yang, Yuan Li, Jianping Zhang, Vincent Kam Wai Wong, Zhihong Jiang. Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-1005-y
|
| 93 |
Eda Becer, Ergül Mutlu Altundag, K. Hüsnü Can Başer, Hafize Seda Vatansever. Cytotoxic activity and antioxidant effects ofOriganum onitesessential oil and its two major contents, carvacrol andp-cymene on human colorectal (HCT116) and hepatocelluler carcinoma (HepG2) cell lines. Journal of Essential Oil Research 2022; 34(6): 514 doi: 10.1080/10412905.2022.2107101
|
| 94 |
Guangjie Zhan, Tiantian Wei, Huichen Xie, Xiaoming Xie, Jun Hu, Hao Tang, Yating Cheng, Huaifeng Liu, Shujing Li, Guohua Yang. Autophagy inhibition mediated by trillin promotes apoptosis in hepatocellular carcinoma cells via activation of mTOR/STAT3 signaling. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1575 doi: 10.1007/s00210-023-02700-5
|
| 95 |
Mei Guo. Cellular senescence and liver disease: Mechanisms and therapeutic strategies. Biomedicine & Pharmacotherapy 2017; 96: 1527 doi: 10.1016/j.biopha.2017.11.075
|
| 96 |
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
|
| 97 |
Dong Gui Hu, Shashikanth Marri, Ross A. McKinnon, Peter I. Mackenzie, Robyn Meech. Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma. Journal of Pharmacology and Experimental Therapeutics 2019; 368(3): 363 doi: 10.1124/jpet.118.255018
|
| 98 |
Yangyang Hui, Binxin Cui, Xiaoyu Wang, Mingyu Sun, Yifan Li, Wanting Yang, Gaoyue Guo, Lihong Mao, Zihan Yu, Xiaofei Fan, Chao Sun. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis 2022; 1(1): 42 doi: 10.1002/poh2.10
|
| 99 |
Yaokai Ma, Guowei Liu, Jinzu Yang, Xin Li, Xiyi Yang, Shiming Fang, Baocheng Zhao, Mohammad Farukh Hashmi. The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid‐/Late‐Stage Hepatocellular Carcinoma. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/9316873
|
| 100 |
Ehab Mohammed. Improved liver function after high dose intravenous vitamin C and Helxior SC injections in a patient with hepatocellular carcinoma progressed after chemotherapy and radiation. Journal of Cancer Prevention & Current Research 2018; 9(4) doi: 10.15406/jcpcr.2018.09.00350
|
| 101 |
Hai-Na Xie, Yu-Yuan Chen, Guo-Biao Zhu, Hai-Hao Han, Xi-Le Hu, Zhi-Qiang Pan, Yi Zang, Dong-Hao Xie, Xiao-Peng He, Jia Li, Tony D. James. Targeted delivery of maytansine to liver cancer cells via galactose-modified supramolecular two-dimensional glycomaterial. Chemical Communications 2022; 58(32): 5029 doi: 10.1039/D1CC06809A
|
| 102 |
Yong Qin, Chao‐Jun Wang, Hai‐Lin Ye, Guan‐Xiong Ye, Shi Wang, De‐Biao Pan, Jun Wang, He‐Juan Shen, Sheng‐Qian Xu. WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma. Cell Biology International 2022; 46(10): 1682 doi: 10.1002/cbin.11856
|
| 103 |
Pietro Gatti, Antonio Giorgio, Emanuela Ciracì, Italia Roberto, Alessandro Anglani, Spano Sergio, Fernando Rizzello, Valentina Giorgio, Stefano Semeraro. Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report. Journal of Ultrasound 2019; 22(3): 363 doi: 10.1007/s40477-019-00361-w
|
| 104 |
Young-Seon Kim, Yoon-Mi Lee, Taek-In Oh, Dong Hoon Shin, Geon-Hee Kim, Sang-Yeon Kan, Hyeji Kang, Ji Hyung Kim, Byeong Mo Kim, Woo Jong Yim, Ji-Hong Lim. Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism. International Journal of Molecular Sciences 2018; 19(10): 3127 doi: 10.3390/ijms19103127
|
| 105 |
Rama Rao Malla, Seema Kumari, Deepak Kgk, Saimila Momin, Ganji Purnachandra Nagaraju. Nanotheranostics: Their role in hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2020; 151: 102968 doi: 10.1016/j.critrevonc.2020.102968
|
| 106 |
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
|
| 107 |
Mohamed H. El-Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, Hany E. A. Ahmed, Mona S. El-Zoghbi, Khaled El-Adl, Hamada S. Abulkhair. 1,2,4-Triazolo[4,3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity. New Journal of Chemistry 2021; 45(25): 11136 doi: 10.1039/D1NJ00710F
|
| 108 |
Jae Min Jung, Seong Han Kim, V. H. Giang Phan, Thavasyappan Thambi, Doo Sung Lee. Therapeutic effects of boronate ester cross-linked injectable hydrogels for the treatment of hepatocellular carcinoma. Biomaterials Science 2021; 9(21): 7275 doi: 10.1039/D1BM00881A
|
| 109 |
Hamdoon A. Mohammed, Suliman A. Almahmoud, Minhajul Arfeen, Ashish Srivastava, Mahmoud Z. El-Readi, Ehab A. Ragab, Safia M. Shehata, Salman A.A. Mohammed, Ehab M. Mostafa, Hend A. El-khawaga, Riaz A. Khan. Phytochemical profiling, molecular docking, and anti-hepatocellular carcinoid bioactivity of extracts. Arabian Journal of Chemistry 2022; 15(7): 103950 doi: 10.1016/j.arabjc.2022.103950
|
| 110 |
Nadire Özenver, Thomas Efferth. Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining. Pharmaceutics 2023; 15(2): 427 doi: 10.3390/pharmaceutics15020427
|
| 111 |
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 227 doi: 10.1016/B978-0-323-98807-0.00020-X
|
| 112 |
Minshan Lai, Qiang Liu, Wenbo Chen, Xuxin Qi, Jianfeng Yang, Li Jiang, Meng Yuan, Zhichun Liu, Qiaojun He, Ji Cao, Bo Yang, Jayeeta Ghose. Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/8346816
|
| 113 |
Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi, Ajaikumar B. Kunnumakkara. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. Cancer Letters 2023; 556: 216066 doi: 10.1016/j.canlet.2023.216066
|
| 114 |
Erika Araujo, Ian M. Bell, Alexander Burckle, Dennis C. Koester, James R. Manning, Richard D. Caldwell, Georgette Castanedo, Samantha A. Green, Mingshuo Zeng, Laurent Debien, T. G. Murali Dhar, Natalie Holmberg-Douglas, Eric R. Welin, J. Robert Merritt, Kevin M. Peese, Denise C. Grünenfelder, Julian C. Lo. 2022 Medicinal Chemistry Reviews. Medicinal Chemistry Reviews 2022; 57: 587 doi: 10.1021/mc-2022-vol57.ch24
|
| 115 |
Ritesh Urade, Wen-Tsan Chang, Ching-Chung Ko, Ruei-Nian Li, Hui-Min Yang, Hsuan-Yu Chen, Lin-Ya Huang, Meng-Yang Chang, Chang-Yi Wu, Chien-Chih Chiu. A fluorene derivative inhibits human hepatocellular carcinoma cells by ROS-mediated apoptosis, anoikis and autophagy. Life Sciences 2023; 329: 121835 doi: 10.1016/j.lfs.2023.121835
|
| 116 |
Adi Zheng, Nadja Chevalier, Margot Calderoni, Gilles Dubuis, Olivier Dormond, Panos G. Ziros, Gerasimos P. Sykiotis, Christian Widmann. CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma. Oncotarget 2019; 10(66): 7058 doi: 10.18632/oncotarget.27361
|
| 117 |
Jianrong Cao, Keze Hong, Chengqi Lv, Weiting Jiang, Qi Chen, Rongze Wang, Yong Wang. Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer. Biomaterials Science 2024; 12(10): 2626 doi: 10.1039/D3BM02136J
|
| 118 |
Leilei Ai, Ziheng Xu, Bo Yang, Qiaojun He, Peihua Luo. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management. Expert Review of Clinical Pharmacology 2019; 12(12): 1121 doi: 10.1080/17512433.2019.1689122
|
| 119 |
Tianze Li. SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance. American Journal of Cancer Research 2024; 14(5): 2326 doi: 10.62347/KGCL7357
|
| 120 |
Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen, Feng Feng, Wei Qu. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway. Current Cancer Drug Targets 2019; 19(7): 583 doi: 10.2174/1568009619666181226094814
|
| 121 |
Natashya Falcone, Menekse Ermis, Ankit Gangrade, Auveen Choroomi, Patric Young, Tess G. Mathes, Mahsa Monirizad, Fatemeh Zehtabi, Marvin Mecwan, Marco Rodriguez, Yangzhi Zhu, Youngjoo Byun, Ali Khademhosseini, Natan Roberto de Barros, Han‐Jun Kim. Drug‐Eluting Shear‐Thinning Hydrogel for the Delivery of Chemo‐ and Immunotherapeutic Agents for the Treatment of Hepatocellular Carcinoma. Advanced Functional Materials 2024; 34(8) doi: 10.1002/adfm.202309069
|
| 122 |
Yizhou Wang, Qing Wang, Shuangfen Tao, Haoyu Li, Xiaofeng Zhang, Yong Xia, Yue Wang, Cheng Yang, Chengjun Sui. Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer. Cancer Letters 2024; 604: 217199 doi: 10.1016/j.canlet.2024.217199
|
| 123 |
Shahla Kianamiri, Ali Dinari, Majid Sadeghizadeh, Mohsen Rezaei, Bahram Daraei, Noor El-Huda Bahsoun, Alireza Nomani. Mitochondria-Targeted Polyamidoamine Dendrimer–Curcumin Construct for Hepatocellular Cancer Treatment. Molecular Pharmaceutics 2020; 17(12): 4483 doi: 10.1021/acs.molpharmaceut.0c00566
|
| 124 |
WeiLu Jia, YingHui Han, XinYu Mao, WenJing Xu, YeWei Zhang. Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment. RSC Advances 2022; 12(48): 31068 doi: 10.1039/D2RA05127C
|
| 125 |
Dung Thi Nguyen, Duong Hoang Nguyen, Van Thi Hong Nguyen. Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation. Journal of International Medical Research 2023; 51(6) doi: 10.1177/03000605231179928
|
| 126 |
Peng Song, Yang Hai, Wantong Ma, Longhe Zhao, Xin Wang, Qinjian Xie, Yang Li, Zhengrong Wu, Yingdong Li, Hongyu Li. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma. Medicine 2018; 97(18): e0613 doi: 10.1097/MD.0000000000010613
|
| 127 |
Jun Liu, Yueying Li, Xiaoming Yang, Yan Dong, Jing Wu, Min Chen. Effects of ginkgol C17:1 on cisplatin‑induced autophagy and apoptosis in HepG2 cells. Oncology Letters 2017; doi: 10.3892/ol.2017.7398
|
| 128 |
Mina Afrashteh Nour, Fatemeh Kheradmand, Yousef Rasmi, Behzad Baradaran. Alpha7 nicotinic acetylcholine receptor expression in Sorafenib-resistant Hepatocellular carcinoma cells. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01745-5
|
| 129 |
Su Youn Baek, Ui Wook Hwang, Ho Young Suk, Young Woo Kim. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma. Biomolecules 2020; 10(5): 713 doi: 10.3390/biom10050713
|
| 130 |
Xianlong Wang, Aleksandra Rusin, Christopher J. Walkey, Justin J. Lin, Deborah L. Johnson. The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis. Journal of Biological Chemistry 2019; 294(50): 19255 doi: 10.1074/jbc.RA119.008849
|
| 131 |
Siqin Li, Fang Liang, Dongdong Huang, Huanling Wu, Xiaohua Tan, Jiang Ma, Caihong Wei, Shixiong Wang, Ziying Huang, Guang Yang, Xin He, Ji Yang. Diterpenoids from the Aerial Parts of Isodon serra with Selective Cytotoxic Activity. Molecules 2024; 29(12): 2733 doi: 10.3390/molecules29122733
|
| 132 |
Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. International Immunopharmacology 2021; 91: 107308 doi: 10.1016/j.intimp.2020.107308
|
| 133 |
Aibin Liu, Yanyan Li, Lin Shen, Liangfang Shen, Zhanzhan Li. Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size. Aging 2022; 14(6): 2645 doi: 10.18632/aging.203963
|
| 134 |
Danping Huang, Weiqu Yuan, Hanmin Li, Shaodong Li, Zuanguang Chen, Hongzhi Yang. Identification of key pathways and biomarkers in sorafenib‑resistant hepatocellular carcinoma using bioinformatics analysis. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6427
|
| 135 |
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
|